These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 34700208)
21. Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database. Billioti de Gage S; Collin C; Le-Tri T; Pariente A; Bégaud B; Verdoux H; Dray-Spira R; Zureik M CNS Drugs; 2018 Jul; 32(7):673-684. PubMed ID: 29959758 [TBL] [Abstract][Full Text] [Related]
22. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. Coupland C; Dhiman P; Morriss R; Arthur A; Barton G; Hippisley-Cox J BMJ; 2011 Aug; 343():d4551. PubMed ID: 21810886 [TBL] [Abstract][Full Text] [Related]
23. Depression ratings and antidepressant use among outpatient heart failure patients: implications for the screening and treatment of depression. Jiménez JA; Redwine LL; Rutledge TR; Dimsdale JE; Pung MA; Ziegler MG; Greenberg BH; Mills PJ Int J Psychiatry Med; 2012; 44(4):315-34. PubMed ID: 23885515 [TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness and cost-utility of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and tricyclic antidepressants in depression with comorbid cardiovascular disease. Pan YJ; Kuo KH; Chan HY; McCrone P J Psychiatr Res; 2014 Jul; 54():70-8. PubMed ID: 24679672 [TBL] [Abstract][Full Text] [Related]
25. Antidepressants for people with epilepsy and depression. Maguire MJ; Marson AG; Nevitt SJ Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531 [TBL] [Abstract][Full Text] [Related]
26. The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analyses. Machado M; Iskedjian M; Ruiz IA; Einarson TR Pharmacoeconomics; 2007; 25(11):979-90. PubMed ID: 17960955 [TBL] [Abstract][Full Text] [Related]
27. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants. Poret AW; Neslusan C; Ricci JF; Wang S; Khan ZM; Kwong JW Value Health; 2001; 4(5):362-9. PubMed ID: 11705126 [TBL] [Abstract][Full Text] [Related]
28. Use of antidepressant medications: are there differences in psychiatric visits among patient treatments in the Veterans Administration? Hamed A; Lee A; Ren XS; Miller DR; Cunningham F; Zhang H; Kazis LE Med Care; 2004 Jun; 42(6):551-9. PubMed ID: 15167323 [TBL] [Abstract][Full Text] [Related]
29. Fluoxetine versus other types of pharmacotherapy for depression. Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD004185. PubMed ID: 24353997 [TBL] [Abstract][Full Text] [Related]
30. Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden. Zoega H; Kieler H; Nørgaard M; Furu K; Valdimarsdottir U; Brandt L; Haglund B PLoS One; 2015; 10(12):e0144474. PubMed ID: 26657647 [TBL] [Abstract][Full Text] [Related]
31. Treatment of depression in patients with cardiovascular diseases by German psychiatrists. Konrad M; Jacob L; Rapp MA; Kostev K Int J Clin Pharmacol Ther; 2016 Aug; 54(8):557-63. PubMed ID: 27125775 [TBL] [Abstract][Full Text] [Related]
32. Prevalence and type of antidepressant therapy used by German general practitioners to treat female patients with osteoporosis . Drosselmeyer J; Rapp MA; Kostev K Int J Clin Pharmacol Ther; 2016 Oct; 54(10):743-9. PubMed ID: 27443661 [TBL] [Abstract][Full Text] [Related]
33. Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study. Dörks M; Langner I; Dittmann U; Timmer A; Garbe E Eur Child Adolesc Psychiatry; 2013 Aug; 22(8):511-8. PubMed ID: 23455627 [TBL] [Abstract][Full Text] [Related]
34. One-year costs of second-line therapies for depression. Sullivan EM; Griffiths RI; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH J Clin Psychiatry; 2000 Apr; 61(4):290-8. PubMed ID: 10830151 [TBL] [Abstract][Full Text] [Related]
35. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials. Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920 [TBL] [Abstract][Full Text] [Related]
36. Gender-based differences in the antidepressant treatment of patients with depression in German psychiatric practices. Jacob L; Kostev K Ger Med Sci; 2016; 14():Doc02. PubMed ID: 26941590 [TBL] [Abstract][Full Text] [Related]
37. Antidepressant adherence and medical resource use among managed care patients with anxiety disorders. Stein MB; Cantrell CR; Sokol MC; Eaddy MT; Shah MB Psychiatr Serv; 2006 May; 57(5):673-80. PubMed ID: 16675762 [TBL] [Abstract][Full Text] [Related]
38. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Schlienger RG; Fischer LM; Jick H; Meier CR Drug Saf; 2004; 27(14):1157-65. PubMed ID: 15554748 [TBL] [Abstract][Full Text] [Related]
39. Weight outcomes among antidepressant users in nursing facilities. Rigler SK; Webb MJ; Redford L; Brown EF; Zhou J; Wallace D J Am Geriatr Soc; 2001 Jan; 49(1):49-55. PubMed ID: 11207842 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological treatment of depression with and without headache disorders: an appraisal of cost effectiveness and cost utility of antidepressants. Pan YJ; Kuo KH; Wang SJ J Affect Disord; 2015 Jan; 170():255-65. PubMed ID: 25261631 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]